chrX-110200911-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015365.3(AMMECR1):c.887+43T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0061 in 1,008,455 control chromosomes in the GnomAD database, including 219 homozygotes. There are 1,528 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 127 hom., 864 hem., cov: 23)
Exomes 𝑓: 0.0032 ( 92 hom. 664 hem. )
Consequence
AMMECR1
NM_015365.3 intron
NM_015365.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.322
Genes affected
AMMECR1 (HGNC:467): (AMMECR nuclear protein 1) The exact function of this gene is not known, however, submicroscopic deletion of the X chromosome including this gene, COL4A5, and FACL4 genes, result in a contiguous gene deletion syndrome, the AMME complex (Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-110200911-A-T is Benign according to our data. Variant chrX-110200911-A-T is described in ClinVar as [Benign]. Clinvar id is 1287673.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0994 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMMECR1 | NM_015365.3 | c.887+43T>A | intron_variant | ENST00000262844.10 | NP_056180.1 | |||
AMMECR1 | NM_001025580.2 | c.776+43T>A | intron_variant | NP_001020751.1 | ||||
AMMECR1 | NM_001171689.2 | c.518+43T>A | intron_variant | NP_001165160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMMECR1 | ENST00000262844.10 | c.887+43T>A | intron_variant | 1 | NM_015365.3 | ENSP00000262844.5 |
Frequencies
GnomAD3 genomes AF: 0.0293 AC: 3283AN: 112001Hom.: 127 Cov.: 23 AF XY: 0.0251 AC XY: 859AN XY: 34207
GnomAD3 genomes
AF:
AC:
3283
AN:
112001
Hom.:
Cov.:
23
AF XY:
AC XY:
859
AN XY:
34207
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00882 AC: 1500AN: 170133Hom.: 51 AF XY: 0.00572 AC XY: 322AN XY: 56307
GnomAD3 exomes
AF:
AC:
1500
AN:
170133
Hom.:
AF XY:
AC XY:
322
AN XY:
56307
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00319 AC: 2861AN: 896401Hom.: 92 Cov.: 13 AF XY: 0.00263 AC XY: 664AN XY: 252187
GnomAD4 exome
AF:
AC:
2861
AN:
896401
Hom.:
Cov.:
13
AF XY:
AC XY:
664
AN XY:
252187
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0294 AC: 3291AN: 112054Hom.: 127 Cov.: 23 AF XY: 0.0252 AC XY: 864AN XY: 34270
GnomAD4 genome
AF:
AC:
3291
AN:
112054
Hom.:
Cov.:
23
AF XY:
AC XY:
864
AN XY:
34270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at